SW
FRTX

SVB Wealth’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

SVB Wealth’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8
Closed -$12K – 567
2015
Q3 		$12K Hold
8
– – ﹤0.01% 544
2015
Q2 		$18K Hold
8
– – ﹤0.01% 555
2015
Q1 		$24K Hold
8
– – ﹤0.01% 550
2014
Q4 		$26K Buy
+8
New +$28.3K ﹤0.01% 537

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SAIG
Semper Augustus Investments Group Highlands Ranch, Colorado $885M AUM 30.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SVB Wealth's FRTX Position: Q4 2015 in Review

SVB Wealth sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2015, closing a stake of 8 shares — an estimated $12K sold.

SVB Wealth first reported a position in FRTX in Q4 2014 and held it in 4 quarters. The position peaked at $26K in Q4 2014. 41 funds tracked by Wall St. Rank hold FRTX as of Q4 2015.

  • SVB Wealth reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • SVB Wealth sold 8 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $12K.
  • SVB Wealth first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2014 and held it in 4 quarters.
  • SVB Wealth's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $26K in Q4 2014.
  • 41 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2015.

Based on SVB Wealth's 13F filing for Q4 2015, filed 12 Feb 2016.